Drug Trial Radar · NCT03463187
Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis
Last checked: Nov 19, 2026Latest source record: Aug 8, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
211
Actual
Start
Dec 15, 2017
Primary completion
Aug 31, 2020
Study completion Aug 31, 2020
Sponsor
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 13, 2018
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-regional, randomized, double-blind, placebo-controlled, clinical trial to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of SHR-1314 in adults with moderate-to-severe plaque psoriasis.
Conditions
- Moderate-to-severe Chronic Plaque Psoriasis
Interventions
SHR-1314Biological
Administered subcutaneously
PlaceboDrug
Administered subcutaneously
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Clinically Significant Events (Part A)Time frame: From baseline through 24 weeks
- Pharmacokinetics (PK) of SHR-1314 (Part A)Time frame: From baseline through 24 weeks
- Pharmacokinetics (PK) of SHR-1314 (Part A)Time frame: From baseline through 24 weeks
- Percentage of Participants With Anti-SHR-1314 Antibodies (Part A)Time frame: From baseline through 24 weeks
- Percentage of subjects who achieve Psoriasis Area Severity Index (PASI) score 75 (Part B)Time frame: From baseline through 12 weeks
Locations
13 sites in 3 countries. Site status is shown where the registry gives one.
Elite Clinical Studies, LLC
Phoenix, Arizona
Anaheim Clinical Trials
Anaheim, California
Revival Research
Doral, Florida
Indago Research and Health Center - Emergency Medicine
Hialeah, Florida
Great Lakes Clinical Trials LLC
Chicago, Illinois
Clinical Partners, LLC
Johnston, Rhode Island
Center for Clinical Studies
Houston, Texas
Center for Clinical Studies
Webster, Texas
St George Dermatology and Skin Cancer Centre - Dermatology
Kogarah, New South Wales, Australia
Westmead Hospital
Westmead, New South Wales, Australia
Veracity Clinical Research Pty Ltd
Woolloongabba, Queensland, Australia
Sinclair Dermatology - Dermatology
East Melbourne, Victoria, Australia
Shanghai Huanshan Hospital Fudan University-Dermatology
Shanghai, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.